Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earnings on Monday, 2026-02-23. Here’s a brief overview of what investors should keep in mind before the announcement.

Analysts expect Axsome Therapeutics to report an earnings per share (EPS) of $-0.72.

The announcement from Axsome Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It’s worth noting for new investors that guidance can be a key determinant of stock price movements.

Performance in Previous Earnings

In the previous earnings release, the …

Full story available on Benzinga.com